Quantcast

Latest Prostate cancer Stories

2014-08-21 23:16:22

Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals, Inc., an oncology company focused on the development of innovative approaches to targeting and treating cancer, to manufacture the anti-prostate specific membrane antigen (PSMA) monoclonal antibody used in Progenics’ PSMA ADC product candidate. St. Louis, MO (PRWEB) August 21, 2014 Gallus...

2014-08-21 16:24:50

ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 21, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing as planned per the recommendation of the Independent Data Monitoring Committee (IDMC) based upon completion of the...

2014-08-21 12:29:55

WASHINGTON, Aug. 21, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer is hosting 16 run/walk events across the nation during September, Prostate Cancer Awareness Month, to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. http://photos.prnewswire.com/prnvar/20130129/DC50244LOGO "Thousands are making a choice for a healthy lifestyle and celebrating Prostate Cancer Awareness Month by walking or running," ZERO CEO Jamie...

2014-08-19 16:29:08

Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug. 19, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the $17.5 million convertible note offering announced last Thursday, August 14, 2014, has closed. The three-year notes have a 5% interest rate and are convertible at $7.30 per share of common stock. The...

2014-08-15 23:05:45

Ablative device manufacturer sponsors international focal therapy symposium, highlights HIFU sessions and invites international attendees to connect with key opinion leaders and company management. Charlotte, NC (PRWEB) August 15, 2014 SonaCare Medical, LLC, the global leader in urologic high intensity focused ultrasound (HIFU), is proud to provide platinum support for the upcoming 7th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer. This year’s...

2014-08-14 08:30:20

Company Strengthens Intellectual Property Protection in Additional Global Market DALLAS and NEW YORK, Aug. 14, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a patent for MuGard and ProctiGard has been granted. The patent covers a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders. "Following our recent European...

obesity and cancer
2014-08-14 07:24:04

redOrbit Staff & Wire Reports - Your Universe Online Obesity increases a person’s risk of developing 10 of the most common forms of cancer, and is believed to cause an estimated 12,000 additional cases of the disease each year, experts from the London School of Hygiene and Tropical Medicine (LSHTM) and the Farr Institute of Health Informatics claim in a new study. The research, which was published online Thursday in the UK medical journal The Lancet, looked at the medical data of...

2014-08-13 23:01:47

North Texas Chapter of the Association of Clinical Research Professionals and Baylor Research Institute, join with Myriad Genetics, Lynch Syndrome International, Progeny and Ambry Genetics to bring global expert, Patrick Lynch, JD, MD, to Dallas to present lifesaving information on Lynch syndrome (HNPCC), a hereditary cancer condition, to bring a community outreach presentation, Saturday, August 16, 2014. Dallas, TX (PRWEB) August 13, 2014 The North Texas Chapter of the Association of...

2014-08-13 08:28:55

SYDNEY, Aug. 13, 2014 /PRNewswire/ -- Australia-US biotechnology company, Novogen Ltd. (ASX: NRT, NASDAQ: NVGN), an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia. A total of 28.3M shares were represented in person or by proxy at the meeting, during which the following resolutions were passed (95% in favor): RESOLUTION 1. SUBSEQUENT APPROVAL OF ISSUE OF...

2014-08-12 23:00:48

Leading Purveyor of Premium Tea Helps Further Prostate Cancer Research with Man Kind Tea NOVATO, CALIF. (PRWEB) August 12, 2014 The Republic of Tea, leading purveyor of premium teas, is thrilled to announce that it has surpassed the $500,000 donation mark to the Prostate Cancer Foundation (PCF) with sales from its Blueberry Green Superfruit™ Tea. The Republic of Tea currently donates $1 from the sale of each full-size tin and $0.36 from the sale of each traveler’s tin directly to PCF....


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related